Sale!

Immunohistochemistry MDM2 Test

470 د.إ

-11%

Immunohistochemistry (IHC) MDM2 test is a specialized diagnostic procedure aimed at detecting the MDM2 protein expression in various tissue samples. MDM2 is an important oncoprotein that plays a crucial role in cell cycle regulation and apoptosis. Its overexpression is often associated with a number of cancers, including sarcomas, making this test a valuable tool in oncology for both diagnosis and therapeutic strategy planning.

Performed at DNA Labs UAE, the IHC MDM2 test involves the application of specific antibodies to tissue sections, which are then visualized under a microscope to determine the presence and level of MDM2 protein. This method allows for precise localization and quantification of protein expression within the cells, providing critical insights into the molecular pathology of the tumor.

The cost of the IHC MDM2 test at DNA Labs UAE is 470 AED. This fee covers the technical process of staining the tissue sample, the expertise of the pathologists in interpreting the results, and the comprehensive report provided. For patients and healthcare providers, this test represents a valuable investment in achieving a detailed understanding of the tumor’s characteristics, which is essential for tailoring the most effective treatment plan.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY MDM2 Test

Test Name: IMMUNOHISTOCHEMISTRY MDM2 Test

Components: Immunohistochemistry

Price: 470.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days

Test Type: Cancer

Doctor: Oncologist, Pathologist

Test Department: HISTOLOGY

Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details:

The MDM2 immunohistochemistry (IHC) test is used to detect the expression of MDM2 protein in tissue samples. MDM2 is an oncogene that plays a critical role in regulating the tumor suppressor protein p53. It acts as a negative regulator of p53, promoting its degradation and inhibiting its transcriptional activity.

The MDM2 IHC test involves the use of specific antibodies that bind to the MDM2 protein in tissue sections. This allows for the visualization and quantification of MDM2 expression within the cells. The test is commonly performed on formalin-fixed, paraffin-embedded tissue samples obtained from biopsies or surgical resections.

The MDM2 IHC test is primarily used in the diagnosis and prognosis of various cancers, including soft tissue sarcomas, liposarcomas, and certain types of lymphomas. Elevated levels of MDM2 expression have been associated with tumor progression, poor prognosis, and resistance to chemotherapy in some cancer types.

Interpretation of the MDM2 IHC test results is typically done by a pathologist who evaluates the staining intensity and distribution within the tissue. The results are reported as positive or negative, indicating the presence or absence of MDM2 protein expression, respectively. In some cases, the staining pattern may also provide additional information about the molecular subtype of the tumor.

It is important to note that the MDM2 IHC test is just one tool in the diagnostic and prognostic evaluation of cancer patients. It is often used in conjunction with other tests, such as molecular genetic analyses, to provide a comprehensive assessment of the disease.

Test Name IMMUNOHISTOCHEMISTRY MDM2 Test
Components
Price 470.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The MDM2 immunohistochemistry (IHC) test is used to detect the expression of MDM2 protein in tissue samples. MDM2 is an oncogene that plays a critical role in regulating the tumor suppressor protein p53. It acts as a negative regulator of p53, promoting its degradation and inhibiting its transcriptional activity.

The MDM2 IHC test involves the use of specific antibodies that bind to the MDM2 protein in tissue sections. This allows for the visualization and quantification of MDM2 expression within the cells. The test is commonly performed on formalin-fixed, paraffin-embedded tissue samples obtained from biopsies or surgical resections.

The MDM2 IHC test is primarily used in the diagnosis and prognosis of various cancers, including soft tissue sarcomas, liposarcomas, and certain types of lymphomas. Elevated levels of MDM2 expression have been associated with tumor progression, poor prognosis, and resistance to chemotherapy in some cancer types.

Interpretation of the MDM2 IHC test results is typically done by a pathologist who evaluates the staining intensity and distribution within the tissue. The results are reported as positive or negative, indicating the presence or absence of MDM2 protein expression, respectively. In some cases, the staining pattern may also provide additional information about the molecular subtype of the tumor.

It is important to note that the MDM2 IHC test is just one tool in the diagnostic and prognostic evaluation of cancer patients. It is often used in conjunction with other tests, such as molecular genetic analyses, to provide a comprehensive assessment of the disease.